Why the study?
Does short-term administration of dobutamine for 72 hours improve flow-mediated vasodilation in patients with severe congestive heart failure?
Does short-term administration of dobutamine for 72 hours improve flow-mediated vasodilation in patients with severe congestive heart failure?
Short-term dobutamine infusion for 72 hours provides sustained improvement in vascular endothelial function for at least 2 weeks in patients with severe CHF.
Answers are grounded in this paper and cite their sources.
May support endothelial benefits from short-term dobutamine in severe CHF; leaves open need for randomized confirmation.
In patients with severe CHF, short-term administration of dobutamine for 72 hours selectively improves vascular endothelial function for >/=2 weeks.
No takes yet. Share an insight, caveat, or question.
Patel et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: